PAX5 and acute lymphoblastic leukemia: This idea is supported by the findings that mutant forms of human PAX5 are functionally impaired [6, 7] and that restoration of PAX5 expression in a human leukemia cell allows for a progressive maturation of the B-ALL like cells and loss of malignant phenotype [29].